Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bucumolol

Known as: 5-methyl-8-(2-hydroxy-3-t-butylaminopropoxy)coumarin, 8-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-5-methyl-2H-1-benzopyran-2-one 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThe effects of bucumolol (BUC), nadolol (NAD) and nifenalol (NIF) on contractile forces and on action potentials (APs… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1981
1981
Effects of bucumolol, a beta-adrenergic blocking agent, on blood pressure and the renin angiotensin system were studied in… Expand
1981
1981
Acute ligation of the left coronary artery of rats produced abnormal Q-wave in the electrocardiogram, tachycardia and frequent… Expand
1981
1981
The effects of the beta-adrenergic blocking agent bucumolol [dl-5-methyl-8-(2-hydroxy-3-t-butylaminoproxy)coumarin] and its… Expand
1980
1980
The phase 1 study of bucumolol, a new β-blocking agent was carried out to examine its pharmacological actions and safety in… Expand
1980
1980
In order to find out an appropriate therapeutic dose of bucumolol, a newly developped β-blocker, the effects of 30mg/day and 60mg… Expand
1979
1979
The beta-blocking, antiarrhythmic, and local anesthetic effects of the racemic mixture and optical isomers of bucumolol, 5-methyl… Expand